News
12h
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 18, 2025 /PRNewswire/ -- USA ...
The company is positioning BE-Smart for near-term commercialization, targeting the $10 billion esophageal disease testing ...
MONTREAL, June 17, 2025 (GLOBE NEWSWIRE) -- Geomega Resources Inc. (" Geomega ” or the " Corporation ”) (TSX.V: GMA) is ...
BE-Smart represents a significant advance in diagnosis and management of Esophageal disease that affects an estimated 60 million people in the United States Study shows >95% success rate, validating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback